NEW YORK (GenomeWeb News) – Genomics and DNA sequencing services company Agowa genomics has purchased a Roche Genome Sequencer FLX system, Roche said today.
The company, a subsidiary of LGC, said the new sequencer will support its expanded range of services and enable it to meet the growing market demand for higher throughput and capacity in sequencing projects.
The Berlin, Germany-based company offers de novo sequencing of prokaryotic and small eukaryotic genomes; completion of de novo sequencing including resolution of repeats and gap closure; analysis of metagenomes and transcriptomes, normalized cDNA methylation patterns, and pools of tagged fosmids and BACs; and targeted re-sequencing of amplicons and genotyping.
Agowa also said it will use the novel GS FLX Titanium reagents that Roche will launch this fall.
The company said its scientists will work with the new high-throughput sequencing technologies along with LGC’s corporate Research & Technology Division to develop new applications. Agowa also plans to expand its sequencing labs and employ new sequencing specialists and laboratory staff.
Financial terms of the agreement were not released.